CHWY vs PCRX · P/E 45, rev $12.60B vs P/E 174, rev $369.8M
Chewy Inc (CHWY) versus Pacira BioSciences, Inc. (PCRX) — a side-by-side from cached financials, not a winner call.
Chewy Inc (CHWY) is a internet retail company listed on US.
Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CHWY revenue for 2026-02-01 was $12.60B. Net income was $222.8M. Revenue was up 6.2% from 2025-02-02 to 2026-02-01. CHWY currently screens at market cap $16.92B and trailing P/E 45.0.
Latest reported PCRX revenue for 2026-06-30 was $369.8M. Net income was $7.6M. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
CHWY currently screens at market cap $16.92B and trailing P/E 45.0. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
Not investment advice. Open the CHWY and PCRX stock pages for the full models.
Not investment advice.